Pharmaniaga incurs RM178.6mil net loss in fourth quarter


Pharmaniaga said the higher revenue was mainly attributable to stronger demand from the concession, non-concession and Indonesia businesses.

PETALING JAYA: Pharmaniaga Bhd slid into a net loss of RM178.6mil for the fourth quarter ended Dec 31,2019, from a net profit of RM4.4mil in the corresponding quarter in the preceding year.

For the quarter in review, the pharmaceutical company saw its revenue grow 20% to RM715.7mil from RM596.6mil.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , loss , fourth quarter , Indonesian , business , revenue ,

Next In Business News

Nvidia-backed DC firm Nscale files for listing
Raising the standards
Ringgit to trade in narrow range against the US dollar this week
A difficult balancing act looms for Bank of Japan
Secondary market deals point to Keyfield upside
Indonesia retains US$17bil standby funds
Bigger index, selective impact
Multiple drivers to support Uzma in FY27
Paramount settlement talks include promise to stay in California
VW crisis widens with US$11.5bil profit warning

Others Also Read